This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Watch the video and get to know more on older patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI); clopidogrel is an effective alternative to the more potent P2Y12 inhibitor ticagrelor.
MAT-BH-2300393/V1/MAY2023
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.